| Modulating NRF2 in disease: timing is everything M Dodson, MR de la Vega, AB Cholanians, CJ Schmidlin, E Chapman, ... Annual review of pharmacology and toxicology 59, 555-575, 2019 | 359 | 2019 |
| Redox regulation by NRF2 in aging and disease CJ Schmidlin, MB Dodson, L Madhavan, DD Zhang Free Radical Biology and Medicine 134, 702-707, 2019 | 352 | 2019 |
| Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis A Anandhan, M Dodson, CJ Schmidlin, P Liu, DD Zhang Cell chemical biology 27 (4), 436-447, 2020 | 249 | 2020 |
| The intricacies of NRF2 regulation in cancer CJ Schmidlin, A Shakya, M Dodson, E Chapman, DD Zhang Seminars in cancer biology 76, 110-119, 2021 | 63 | 2021 |
| Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2–related factors 1 and 2 (NRF1 and NRF2) W Tian, MR de la Vega, CJ Schmidlin, A Ooi, DD Zhang Journal of Biological Chemistry 293 (6), 2029-2040, 2018 | 63 | 2018 |
| ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A J Tillotson, M Kedzior, L Guimarães, AB Ross, TL Peters, AJ Ambrose, ... Bioorganic & medicinal chemistry letters 27 (17), 4082-4085, 2017 | 34 | 2017 |
| Filtering through the role of NRF2 in kidney disease CJ Schmidlin, MB Dodson, DD Zhang Archives of pharmacal research 43, 361-369, 2020 | 28 | 2020 |
| The NRF2-LOC344887 signaling axis suppresses pulmonary fibrosis P Liu, G Luo, M Dodson, CJ Schmidlin, Y Wei, B Kerimoglu, A Ooi, ... Redox Biology 38, 101766, 2021 | 26 | 2021 |
| A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78 AJ Ambrose, CJ Zerio, J Sivinski, CJ Schmidlin, T Shi, AB Ross, ... Bioorganic & medicinal chemistry letters 29 (14), 1689-1693, 2019 | 19 | 2019 |
| Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolism P Liu, M Dodson, H Li, CJ Schmidlin, A Shakya, Y Wei, JGN Garcia, ... Molecular Metabolism 51, 101243, 2021 | 15 | 2021 |
| FAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells CJ Schmidlin, W Tian, M Dodson, E Chapman, DD Zhang Molecular carcinogenesis 60 (5), 331-341, 2021 | 15 | 2021 |
| Activation of NRF2 by topical apocarotenoid treatment mitigates radiation-induced dermatitis CJ Schmidlin, MR de la Vega, J Perer, DD Zhang, GT Wondrak Redox Biology 37, 101714, 2020 | 15 | 2020 |
| Chronic arsenic exposure enhances metastatic potential via NRF2-mediated upregulation of SOX9 CJ Schmidlin, T Zeng, P Liu, Y Wei, M Dodson, E Chapman, DD Zhang Toxicology and applied pharmacology 402, 115138, 2020 | 15 | 2020 |
| CHML is an NRF2 target gene that regulates mTOR function M Dodson, W Dai, A Anandhan, CJ Schmidlin, P Liu, NC Wilson, Y Wei, ... Molecular Oncology 16 (8), 1714-1727, 2022 | 4 | 2022 |
| Discovery and development of a selective inhibitor of the ER resident chaperone Grp78 AJ Ambrose, J Sivinski, CJ Zerio, X Zhu, J Godek, VK Kumirov, ... Journal of Medicinal Chemistry 66 (1), 677-694, 2022 | 3 | 2022 |
| The Temporal and Contextual Relationship of NRF2 Activation and Cancer CJ Schmidlin The University of Arizona, 2021 | 1 | 2021 |
Donna D. ZhangUniversity of ArizonaEmail confirmado em pharmacy.arizona.edu
